Combination therapies for cancer and proliferative angiopathies

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/282 (2006.01) A61K 31/7064 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2563305

Compositions and methods for treating cancer and proliferative angiopathies are provided. A composition can include an inhibitor of the Jak2/Stat3 signaling pathway and an inhibitor of the PI3k/Akt signaling pathway. In certain cases, the two inhibitors are capable of acting synergistically as compared to either inhibitor alone.

L'invention concerne des compositions et des procédés permettant de traiter le cancer et des angiopathies proliférantes. Une composition de cette invention peut comprendre un inhibiteur du trajet de signalisation Jak2/Stat3 et un inhibiteur du trajet de signalisation PI3k/Akt. Dans certains cas, les deux inhibiteurs sont capables d'agir en synergie, par opposition à chaque inhibiteur seul.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination therapies for cancer and proliferative angiopathies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapies for cancer and proliferative angiopathies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapies for cancer and proliferative angiopathies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1840964

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.